Growth Metrics

Biomarin Pharmaceutical (BMRN) Acquisitions (2016)

Biomarin Pharmaceutical's Acquisitions history spans 5 years, with the latest figure at $1.3 million for Q4 2016.

  • For the quarter ending Q4 2016, Acquisitions changed N/A year-over-year to $1.3 million, compared with a TTM value of $1.3 million through Dec 2017, changed 0.0%, and an annual FY2016 reading of $2.8 million, down 99.48% over the prior year.
  • Acquisitions for Q4 2016 was $1.3 million at Biomarin Pharmaceutical, down from $538.4 million in the prior quarter.
  • The five-year high for Acquisitions was $538.4 million in Q1 2015, with the low at $1.3 million in Q4 2016.
  • Average Acquisitions over 3 years is $183.2 million, with a median of $9.9 million recorded in 2013.